about
Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamicsNMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme.The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity.Getting the chemistry right: protonation, tautomers and the importance of H atoms in biological chemistry.
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
NMR spectroscopy in structure-based drug design.
@ast
NMR spectroscopy in structure-based drug design.
@en
type
label
NMR spectroscopy in structure-based drug design.
@ast
NMR spectroscopy in structure-based drug design.
@en
prefLabel
NMR spectroscopy in structure-based drug design.
@ast
NMR spectroscopy in structure-based drug design.
@en
P1476
NMR spectroscopy in structure-based drug design.
@en
P2093
Roberts GC
P356
10.1016/S0958-1669(99)80008-1
P577
1999-02-01T00:00:00Z